Results 121 to 130 of about 810,489 (200)

Efficacy of eravacycline on carbapenem resistant Enterobacterales in vitro

open access: yes, 2019
The main obstacle in treatment of infections caused by carbapenem-resistant Enterobacterales (CRE) are limited treatment options. The novel antimicrobial agents other than β-lactams with activity not being dependent on β-lactamase class are especially important.
openaire   +1 more source

The Practicability of Carbapenem-resistant Enterobacterales Surveillance Culture

open access: yesKorean Journal of Healthcare-Associated Infection Control and Prevention, 2023
openaire   +1 more source

Carbapenem-resistant Enterobacterales peri-rectal colonization prevalence on admission to two intensive care units in an academic hospital in India

open access: yes
This study from a South Indian tertiary care hospital found a 41% peri-rectal Carbapenem-resistant Enterobacterales colonization prevalence at intensive care unit admission, with New Delhi metallo-β-lactamase as the predominant carbapenemase.
Petersen, Emily E   +34 more
core   +1 more source

Antimicrobial Resistance Trends in Carbapenem-Resistant Enterobacterales in a Saudi Healthcare Setting. [PDF]

open access: yesMicroorganisms
Alghamdi WA   +4 more
europepmc   +1 more source

Carbapenem-resistant Enterobacterales infection at a South African paediatric hospital. [PDF]

open access: yesBMC Infect Dis
Bockarie Y   +4 more
europepmc   +1 more source

Prevalence and molecular typing of carbapenem-resistant Enterobacterales in a secondary-care hospital in Jazan region, Saudi Arabia. [PDF]

open access: yesNew Microbes New Infect
Alshafie H   +7 more
europepmc   +1 more source

Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon. [PDF]

open access: yesJAC Antimicrob Resist
Tannous J   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy